As of June 20, 2025, Resapp Health Ltd (RAP.AX) reports a Gross Margin of 39.01%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing Resapp Health Ltd's Gross Margin to Peers
To better understand Resapp Health Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Resapp Health Ltd (RAP.AX) | 39.01% |
| 1st Group Ltd (1ST.AX) | 100.74% |
| Tali Digital Ltd (TD1.AX) | 100.00% |
| TrivarX Ltd (MEB.AX) | 99.98% |
| Pro Medicus Ltd (PME.AX) | 99.82% |
| SyntekaBio Inc (226330.KQ) | 95.51% |
Compared to its competitors, Resapp Health Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.